(OTLK) Outlook Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Outlook Therapeutics | (OTLK) share price targets
Complete technical analysis of Outlook Therapeutics (OTLK) by charts plus indicators, forecast predictions and share price targets for Outlook Therapeutics (OTLK)
Outlook Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-04-11 View latest technical analysis
10 day averaged volume of Outlook Therapeutics is 820550
Date | Daily Closing Price | Open | High | Low | Volume |
11 Thu Apr 2024 | 9.04 | 9.09 | 9.34 | 8.75 | 0.48 times |
10 Wed Apr 2024 | 8.99 | 9.06 | 9.15 | 8.55 | 0.613 times |
09 Tue Apr 2024 | 9.26 | 9.35 | 9.98 | 9.03 | 0.438 times |
08 Mon Apr 2024 | 9.35 | 9.23 | 9.48 | 8.89 | 0.302 times |
05 Fri Apr 2024 | 9.26 | 9.50 | 9.61 | 9.05 | 0.242 times |
04 Thu Apr 2024 | 9.52 | 9.20 | 9.86 | 8.74 | 1.092 times |
03 Wed Apr 2024 | 9.12 | 9.78 | 10.21 | 9.00 | 0.944 times |
02 Tue Apr 2024 | 9.70 | 10.33 | 10.95 | 8.85 | 1.238 times |
01 Mon Apr 2024 | 10.26 | 12.36 | 12.85 | 9.95 | 1.444 times |
28 Thu Mar 2024 | 11.94 | 9.39 | 12.70 | 9.36 | 1.897 times |
My analysis of stock is bullish for shortterm, and stock might move up till 10 or till 11.6. Use a stoploss of 8.73 and if this stock hits its stoploss, then it can fall down till 7.42
Share price targets for Outlook Therapeutics (OTLK)
Target Type | Value |
Downside Target | 0.29 |
Downside Target | 0.31 |
Downside Target | 0.35 |
Downside Target | 0.46 |
Downside Target | 0.50 |
Downside Target | 6.74 |
Downside Target | 7.70 |
Downside Target | 8.55 |
Downside Target | 8.74 |
Upside Target | 9.98 |
Upside Target | 10.72 |
Upside Target | 11.72 |
Upside Target | 12.70 |
Upside Target | 12.85 |
Intraday share price targets for Outlook Therapeutics (OTLK)
Target Type | Value |
Downside Intraday Target | 8.4 |
Downside Intraday Target | 7.76 |
Upside Intraday Target | 9.83 |
Upside Intraday Target | 10.62 |
Upside Intraday Target | 9.19 |
Weekly technical analysis of Outlook Therapeutics (OTLK)
Date | Weekly Closing Price | Open | High | Low | Volume |
11 Thu Apr 2024 | 9.04 | 9.23 | 9.98 | 8.55 | 0.37 times |
05 Fri Apr 2024 | 9.26 | 12.36 | 12.85 | 8.74 | 0.952 times |
28 Thu Mar 2024 | 11.94 | 8.74 | 12.70 | 7.70 | 0.192 times |
22 Fri Mar 2024 | 8.63 | 8.09 | 11.72 | 6.74 | 1.853 times |
15 Fri Mar 2024 | 8.24 | 0.40 | 10.72 | 0.31 | 2.006 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Outlook Therapeutics (OTLK)
Date | Monthly Closing Price | Open | High | Low | Volume |
11 Thu Apr 2024 | 9.04 | 12.36 | 12.85 | 8.55 | 0.121 times |
28 Thu Mar 2024 | 11.94 | 0.44 | 12.70 | 0.31 | 1.494 times |
29 Thu Feb 2024 | 0.44 | 0.39 | 0.50 | 0.35 | 0.561 times |
31 Wed Jan 2024 | 0.39 | 0.40 | 0.46 | 0.29 | 1.407 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Outlook Therapeutics (OTLK)
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Outlook Therapeutics stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Outlook Therapeutics in short term but the sell signal is initial and weak.
Outlook Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Outlook Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Outlook Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 10.06 and Outlook Therapeutics (OTLK) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Outlook Therapeutics (OTLK) stock. Volume based technical analysis of Outlook Therapeutics (OTLK) stock is negative.
Outlook Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Outlook Therapeutics stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Outlook Therapeutics in short term but the sell signal is initial and weak.
Outlook Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Outlook Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Outlook Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 10.06 and Outlook Therapeutics (OTLK) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Outlook Therapeutics (OTLK) stock. Volume based technical analysis of Outlook Therapeutics (OTLK) stock is negative.
Outlook Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.